0001354488-16-006088.txt : 20160205 0001354488-16-006088.hdr.sgml : 20160205 20160205171211 ACCESSION NUMBER: 0001354488-16-006088 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160205 DATE AS OF CHANGE: 20160205 EFFECTIVENESS DATE: 20160205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tribute Pharmaceuticals Canada Inc. CENTRAL INDEX KEY: 0001159019 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-256901 FILM NUMBER: 161393148 BUSINESS ADDRESS: STREET 1: 544 EGERTON ST CITY: LONDON STATE: A6 ZIP: N5W 3Z8 BUSINESS PHONE: 519-434-1540 MAIL ADDRESS: STREET 1: 544 EGERTON ST CITY: LONDON STATE: A6 ZIP: N5W 3Z8 FORMER COMPANY: FORMER CONFORMED NAME: STELLAR PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060412 FORMER COMPANY: FORMER CONFORMED NAME: STELLAR INTERNATIONAL INC DATE OF NAME CHANGE: 20010910 D 1 primary_doc.xml X0707 D LIVE 0001159019 Tribute Pharmaceuticals Canada Inc. 151 Steeles Avenue East Milton A6 ONTARIO, CANADA L9T 1Y1 519-434-1540 ONTARIO, CANADA STELLAR PHARMACEUTICALS INC STELLAR INTERNATIONAL INC Corporation true Janice M. Clarke 544 Egerton Street London A6 ONTARIO, CANADA N5W 3Z8 Executive Officer Andrew I. Koven 151 Steeles Avenue East Milton A6 ONTARIO, CANADA L9T 1Y1 Executive Officer Director Murray Roach 151 Steeles Avenue East Milton A6 ONTARIO, CANADA L9T 1Y1 Executive Officer Bernard Chiasson 151 Steeles Avenue East Milton A6 ONTARIO, CANADA L9T 1Y1 Executive Officer Scott J. Charles 151 Steeles Avenue East Milton A6 ONTARIO, CANADA L9T 1Y1 Director Eric L. Trachtenberg 151 Steeles Avenue East Milton A6 ONTARIO, CANADA L9T 1Y1 Director Robert Harris 151 Steeles Avenue East Milton A6 ONTARIO, CANADA L9T 1Y1 Director Pharmaceuticals $5,000,001 - $25,000,000 06b false 2016-02-05 false true true true true Each convertible note bears interest at 2.5% for up to 6 years with at the Conversion Price defined in the Second Amended and Restated Facility Agreement dated December 7, 2015. true 0 75000000 75000000 0 false 3 0 0 0 false Tribute Pharmaceuticals Canada Inc. /s/ Janice Clarke Janice Clarke Vice President Finance and Administration 2016-02-05